SenzaGen AB (OSTO:SENZA) EPS (Basic): kr-0.46 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SENZA SenzaGen AB OSTO:SENZA
72 GF Score
Price kr5.30
GF Value kr6.41
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is SenzaGen AB EPS (Basic)?

SenzaGen AB OSTO:SENZA -0.75% 72 EPS (Basic) is kr-0.46 as of Mar. 2026. GuruFocus rates OSTO:SENZA with a GF Score™ of 72/100 and a GF Value™ of kr6.41 (Modestly Undervalued). The stock has 5 warning signs investors should review.

SenzaGen AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was kr-0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.46.

SenzaGen AB's EPS (Diluted) for the three months ended in Mar. 2026 was kr-0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.46.

SenzaGen AB's EPS without NRI for the three months ended in Mar. 2026 was kr-0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.33.

During the past 3 years, the average EPS without NRI Growth Rate was 21.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 23.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, SenzaGen AB's highest 3-Year average EPS without NRI Growth Rate was 35.70% per year. The lowest was -59.10% per year. And the median was 13.25% per year.

SenzaGen AB  (OSTO:SENZA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

SenzaGen AB EPS (Basic) Related Terms

SenzaGen AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for SenzaGen AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SenzaGen AB EPS (Basic) Chart

SenzaGen AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.35 -1.03 -0.91 -0.41 -0.39

SenzaGen AB Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.18 -0.07 -0.15 -0.06
OSTO:SENZA
72GF Score
SenzaGen AB OSTO:SENZA
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SenzaGen AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

SenzaGen AB's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-11.587-0)/29.504
=-0.39

SenzaGen AB's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.917-0)/31.507
=-0.06

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of kr-0.46 mean?
SenzaGen AB (OSTO:SENZA) has a EPS (Basic) of kr-0.46 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on SenzaGen AB and its competitors.
Is SenzaGen AB's EPS (Basic) too high?
SenzaGen AB's current EPS (Basic) is kr-0.46. Overall, SenzaGen AB has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SenzaGen AB's EPS (Basic) compare to TMO and DHR?
SenzaGen AB's EPS (Basic) of kr-0.46 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on SenzaGen AB and its competitors. SenzaGen AB's current EPS (Basic) is kr-0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SenzaGen AB stock overvalued right now?
Based on GuruFocus' analysis, SenzaGen AB (OSTO:SENZA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr6.41, compared to a current price of kr5.30 — trading 17.3% below its estimated fair value. The current EPS (Basic) is kr-0.46. SenzaGen AB's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For SenzaGen AB (OSTO:SENZA), the current EPS (Basic) is kr-0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SenzaGen AB (OSTO:SENZA) Overvalued in 2026?

Based on GuruFocus' analysis, SenzaGen AB stock appears to be undervalued. The current stock price of kr5.30 is trading 17.3% below its estimated GF Value™ of kr6.41. GuruFocus considers SenzaGen AB to be Modestly Undervalued.

Key valuation signals for OSTO:SENZA:

  • EPS (Basic): kr-0.46
  • GF Value™: kr6.41 vs. price of kr5.30 (17.3% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the OSTO:SENZA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SenzaGen AB Business Description

Address Scheelevagen 8, Medicon Village, Building 401, Lund, SWE, 223 63
SenzaGen AB markets, sells, and performs in vitro testing using its Genomic Allergen Rapid Detection (GARD) platform through its laboratory and a network of contract research organizations. The company provides animal-free testing solutions for chemical compounds used in industries such as cosmetics, chemicals, pharmaceuticals, medical devices, and food and nutrition. Geographically, it operates in the Americas, EMEA, and APAC, with the majority of revenue from EMEA.
72GF Score

Get the complete analysis for OSTO:SENZA

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.30
Price
kr6.41
GF Value